Back to Search
Start Over
Priority Paper Alerts.
- Source :
- Future Oncology; Aug2008, Vol. 4 Issue 4, p454-454, 1/3p
- Publication Year :
- 2008
-
Abstract
- The article focuses on the study which seeks to analyze possible remedies for cancer growth in Great Britain. It claims that montesanib diphosphate, an antigiogenic agent (AMG 706), has been evaluated as a potential treatment for progressive differentiated thyroid cancer (PDTC). On the other hand, CTC-chip has been employed in analyzing the isolated circulating tumor cells of epidermal growth factor receptor (EGFR) mutations.
Details
- Language :
- English
- ISSN :
- 14796694
- Volume :
- 4
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- Future Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 33719333